The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
IMHO all, and I mean ALL Companies that AGL now work with will **ALSO** want this "Combined DNA Next Generation Sequencing of CTCs and ctDNA from the same blood sample" for cancer treatment studies that involve metastasized cancer. It is obvious. They *******MUST******* WANT THIS imho. HOW ELSE CAN THEY MONITOR THE CANCER????
"BREAKTHROUGH CLINICAL RESULTS PROVIDE A UNIQUE INSIGHT INTO THE PROGRESSION OF EACH PATIENT'S CANCER.
Combined DNA Next Generation Sequencing of CTCs and ctDNA from the same blood sample highlights potential for the Parsortix system to identify key variants (DNA mutations) missed by other approaches to help guide treatment decisions
The new DNA sample-to-answer molecular solution combining CTC and ctDNA analysis is expected to be a driver of product and pharma services sales".
https://www.lse.co.uk/rns/AGL/breakthrough-clinical-results-b0km788ah9aflqm.html
These agreements to date are just the start.
Angle simply must be in discussions about the "Combined DNA Next Generation Sequencing of CTCs and ctDNA from the same blood sample". It will me massive IMHO..............
All IMHO.
Up 20% now.
See here:-
https://www.lse.co.uk/rns/AGL/new-commercial-agreement-with-large-pharma-gvzk9wgh1la0ljx.html
Https://www.washingtonpost.com/world/2024/05/02/israel-hamas-war-news-gaza-palestine/
Mesquida.
"Surely 37p was the top ofbthe January spoke ?2
======================================
Sorry. My memory said 51p but checking the chart it was arounf 31p! Still over two fold the currect sp of course.
One would have thought. We will see. Like the odds and potential 100% plus profit myself!
All IMHO.
Nudgesta.
"The sp has never been that low??"
======================
Results due this month.
Lowest I remember was about 9.8p Nov 2023. Highest since then 51p ish (spike up due to RNS of 4th Jan 2024 - Cancer breakthrough). Recently spiked to 17p (contract with Astrazeneca). Illiquid share means it moves a lot on low volume (either way). Thus a good news RNS often spikes the sp up a lot.......
Currently 14p.
All IMHO.
I would not be surprised is a bid comes in.
A leading liquid biopsy Company with an FDA cleared machine, contracts with both Eisai and now Astrazeneca........
The market cap is ridiculous if you ask me.
All IMHO.
Due this month.
The original announcement "ANGLE announces partnership with BioView" 19th April 2023:-
https://www.lse.co.uk/rns/AGL/angle-announces-partnership-with-bioview-dvvtkgt3ttabibt.html
The update "Parsortix HER2 assay showcased at AACR 2024" 8th April 2024:
https://www.lse.co.uk/rns/AGL/parsortix-her2-assay-showcased-at-aacr-2024-4k393y7ivsvtwno.html
Due this month - May 2024.
See:-
https://angleplc.com/information-for-investors-angle-plc/financial-reports/#text_grid-1
TwoGood2Die.
I don't mean for the whole Company. LOL!
Hello.
Https://www.lse.co.uk/ShareBrokerTips.html?shareprice=AGL&share=Angle
Https://onlinelibrary.wiley.com/doi/full/10.1002/ijc.34978
Just look at the Companies mentioned in this article:-
***Elena Ioana Braicu receives research funding from Bayer, Roche Diagnostics, Tesaro, GSK, and AstraZeneca and personal fees from AstraZeneca, Clovis, GSK, Tesaro, EISAI, RochePharma, and Roche Diagnostics. Elena Ioana Braicu is a Feodor Lynen fellow of the Humboldt Foundation and a participant in the Charité Clinical Scientist Program funded by the Charité Universitätsmedizin Berlin and the Berlin Institute of Health.
***Philipp Harter receives research funding from Astra Zeneca, Roche, GSK, Genmab, DFG, European Union, DKH, Immunogen, Seagen, Clovis, and Novartis and honoraria from Amgen, Astra Zeneca, GSK, Roche, Sotio, Stryker, Zai Lab, MSD, Clovis, Eisai, Mersana, and Exscientia.
***Philipp Harter is ******an advisory board member******* for Astra Zeneca, Roche, GSK, Clovis, Immunogen, MSD, Miltenyi, Novartis, and Eisai!!!!!!!!!!!!!!!*************.
All IMHO.
Hello.
Hello.
A fortune!
The big Co's shorting could go from a massive profit now to losing. They must be tempted to cash in their winnings to be on the safe side.
One wonders what others are in the pipeline.
There are thousands of Pharma Co's IN THE WORLD. Food for thought TwoGood2Die, is it not!!! LOL!
I think there will be LOADS in the next 4 months. LOADS.
All IMHO.
Angle now have both Eisia In. (top 100 Japanese Co) and Astrazeneca (FTSE 100 Co.) on their books.
Acorns grow to oak trees............